KeyBanc Thinks Physicians Realty Trust’s Stock is Going to Recover

By Jason Carr

KeyBanc analyst Jordan Sadler reiterated a Buy rating on Physicians Realty Trust (NYSE: DOC) yesterday and set a price target of $17. The company’s shares closed yesterday at $15.06, close to its 52-week low of $14.13.

According to, Sadler is a 3-star analyst with an average return of 2.2% and a 52.6% success rate. Sadler covers the Financial sector, focusing on stocks such as National Health Investors, MedEquities Realty Trust, and QTS Realty Trust.

Currently, the analyst consensus on Physicians Realty Trust is Strong Buy and the average price target is $17.56, representing a 16.6% upside.

In a report released yesterday, BMO Capital also reiterated a Buy rating on the stock with a $18 price target.

The company has a one-year high of $21.85 and a one-year low of $14.13. Currently, Physicians Realty Trust has an average volume of 1.63M.

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of DOC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Physicians Realty Trust operates as a real estate investment trust, which leases and manages healthcare properties. It is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties which are leased to physicians, hospitals, and healthcare delivery systems.